Difference between revisions of "Part:BBa K1720005:Design"
(→Design Notes) |
(→Design Notes) |
||
| Line 8: | Line 8: | ||
===Design Notes=== | ===Design Notes=== | ||
The vector we used in our experiment was created using scarless golden gate assembly. | The vector we used in our experiment was created using scarless golden gate assembly. | ||
| − | We cloned this composite part into a psb1c3 vector for standardization. This part contains a U6 promoter we add a sequence that can form hairpin RNA downstream. | + | We cloned this composite part into a psb1c3 vector for standardization. This part contains a U6 promoter and we add a sequence that can form hairpin RNA downstream. |
===Source=== | ===Source=== | ||
Latest revision as of 08:29, 4 September 2015
Human phosphodiesterase 5A gene silencing device NO.3
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal XhoI site found at 273
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
The vector we used in our experiment was created using scarless golden gate assembly. We cloned this composite part into a psb1c3 vector for standardization. This part contains a U6 promoter and we add a sequence that can form hairpin RNA downstream.
Source
We designed the shRNA according to the homology segment sequence of PDE5A from NCBI
References
1. Kukreja RC, Salloum FN, Das A: Cyclic Guanosine Monophosphate Signaling and Phosphodiesterase-5 Inhibitors in Cardioprotection. Journal Of the American College Of Cardiology 2012, 59(22):1921-1927.
2. Li L, Haider HK, Wang L, Lu G, Ashraf M: Adenoviral short hairpin RNA therapy targeting phosphodiesterase 5a relieves cardiac remodeling and dysfunction following myocardial infarction. American Journal Of Physiology-Heart And Circulatory Physiology 2012, 302(10):H2112-H2121.
3. Unwalla HJ, Li HT, Bahner I, Li MJ, Kohn D, Rossi JJ: Novel Pol II fusion promoter directs human immunodeficiency virus type 1-inducible coexpression of a short hairpin RNA and protein. Journal of virology 2006, 80(4):1863-1873.